Intestinal metaplasia is linked to developing gastric cancer and involves significant cellular changes, highlighting its role in disease progression.
ScRNA-seq profiling of IM tissue samples identified key biomarkers associated with gastric cancer, allowing for better disease understanding and potential interventions.
Comprehensive genomic analyses were conducted to uncover characteristics of intestinal metaplasia, contributing to the field's understanding of cancer development.
These findings may underscore the importance of monitoring intestinal metaplasia as a precursor to gastric cancer, indicating a need for further research.